Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Intralesional vs. Perilesional 5% Dextrose Injections for Partial Rotator Cuff Tears

Official title: Comparison of Clinical and Ultrasonographic Outcomes of Intralesional and Perilesional 5% Dextrose Injection in Patients With Partial Rotator Cuff Tears: A Prospective Randomized Double-Blind Controlled Trial

Run by Ankara City Hospital Bilkent · NCT07688902 · Data updated 2026-11-12

This trial tests whether injecting 5% dextrose directly into the tear or around it helps people with partial rotator cuff tears improve shoulder pain and function.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment30 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara)
StatusRecruiting
StartedFebruary 1, 2025
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedJuly 7, 2026
Trial IDNCT07688902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-75 with a clinically and imaging-confirmed partial rotator cuff tear causing at least 3 months of pain and functional limitation.

Probably not a fit

Patients with full-thickness rotator cuff tears or other major shoulder pathologies may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind study compares two ultrasound-guided dextrose injection approaches for partial rotator cuff tears: intralesional injection versus perilesional injection using a peppering technique, given in three sessions 21 days apart. All participants receive ultrasound guidance to the supraspinatus enthesis and follow a home exercise program after treatments. Outcomes and tendon changes are assessed at baseline, 9 weeks, and 12 weeks, with ultrasound review at 12 weeks to evaluate structural changes. The study aims to determine which approach better improves clinical symptoms and tendon morphology in this chronic shoulder condition.

Why it matters

Potential benefit: If successful, the preferred injection approach could provide greater pain relief and improved shoulder function for people with partial rotator cuff tears.

How similar studies have gone: Previous regenerative injection therapy studies suggest potential benefits, but direct head-to-head comparison of intralesional vs perilesional dextrose in partial tears is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of partial rotator cuff tear by a specialist physician after appropriate clinical examination and imaging evaluation
* Shoulder pain and functional limitation lasting for at least 3 months
* Clinically confirmed shoulder impingement findings, defined as at least one positive test among Neer, Hawkins-Kennedy, or painful arc tests
* Age between 18 and 75 years
* Ability to comply with the study procedures and attend follow-up visits regularly
* Willingness to participate in the study and provide written informed consent

Exclusion Criteria:

* Advanced cognitive impairment or dementia preventing reliable completion of questionnaires
* Refusal to participate in the study or inability to provide informed consent
* Full-thickness rotator cuff tear
* Major tendon pathology other than the supraspinatus tendon, such as full-thickness subscapularis tear or biceps tendon rupture
* Advanced acromioclavicular joint osteoarthritis, marked impingement, or marked adhesive capsulitis
* Advanced glenohumeral joint arthritis
* Active infection, cellulitis, or dermatologic lesion at the injection site
* Bleeding diathesis or anticoagulant use
* Known allergy or intolerance to dextrose injection
* Intra-articular shoulder injection, including steroid, platelet-rich plasma, or prolotherapy, within the last 3 months
* Previous shoulder surgery
* Uncontrolled diabetes mellitus, defined as HbA1c \>8.5%, or severe endocrine or metabolic disorder
* Immunosuppression or active infection
* Rheumatologic shoulder involvement
* Neurological disease affecting shoulder movements
* Pregnancy
* Active malignancy

Where it's running

  • Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: ESRA Ülgen Kıratlıoğlu — Ankara City Hospital Bilkent
  • Study coordinator: Esra Ülgen Kıratlıoğlu, MD
  • Email: esraulgen@gmail.com
  • Phone: +905079614194

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.